TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
20 hedge funds and large institutions have $158K invested in Titan Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
+3
Holders Change %
+17.65%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Renaissance Technologies
New York
|
+$47.8K |
2 |
UBS Group
Zurich,
Switzerland
|
+$3.5K |
3 |
Citadel Advisors
Miami,
Florida
|
+$454 |
4 |
Raymond James Financial
St Petersburg,
Florida
|
+$4 |
Top Sellers
1 |
Morgan Stanley
New York
|
-$8 |